Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

The paper that analyzed to what degree the most commonly prescribed immunosuppressants increase the likelihood of melanoma was considered the best communication at the national congress of dermatology

A l'estudi hi participaran 200 persones voluntàries i es durà a terme a 10 hospitals espanyols, entre els quals Vall d’Hebron.

The research team on liver transplantation in children led by Dr. Jesús Quintero has received two awards for the best oral communications and a grant.

The Kidney Transplantation Unit of Vall d'Hebron Hospital was the first European center to include patients in the post-authorization efficacy study, the step prior to approval by the European Medicines Agency.

The paper presents the consensus among 16 experts from around the world analyzing the impact of ECMO during the pandemic.

Six Vall d'Hebron researchers have participated in the meeting organized by the Fetal Medicine Foundation.

The research, published in The Lancet, studied patients in Barcelona and Madrid, and shows that direct contact is the main route of transmission for the disease.

The international study in which Vall d'Hebron participated has found that these women may experience a lower health-related quality of life regardless of how long ago the abuse occurred.

His project reports the increased diagnostic power of high-resolution bowel manometry in patients with suspected small bowel motor disorder compared to conventional technology.

A study published in the Journal of Healthcare Quality Research describes the transformation process at the Vall d’Hebron University Hospital in response to the first few months of the COVID-19 pandemic.

The HepClink project, started in 2019, has been effective in reaching an immigrant population with low knowledge of the disease and that, in general, has not been tested before

 

Es tracta d'un projecte pioner a l'Estat que ha permès detectar més de 128 persones amb el virus actiu, de les quals 40 han estat tractades i curades.

Vall d'Hebron is one of the participants in the CARB-ES-19 research, led by the CIBER, in which 71 hospitals throughout the peninsula have collaborated.

The researcher Carles Rubio presented the research of the VHIR Microbiology research group and the UPC and co-funded by the Probitas Foundation.

Dr. Luz Uria was recognized for the best communication of the Congress of the Sociedad Española de Hematología y Oncología Pediátrica, the second place was for Dr. Raquel Hladun.

The first global study on the prevalence of functional gastrointestinal disorders has been the most successful article.

 

 

Es va reconèixer la tasca de més de 70 professionals dedicades a aquesta malaltia pulmonar, tant assistencial com de recerca.

The meeting allows establishing the basis for collaboration between experts from around the world, with the aim of promoting research on this protein and its role in cancer.

In pediatric cancers, sarcomas account for 14% of cases and 20% of deaths.

Manina Medtech received a direct grant of 75,000 euros from the ACCIÓ Startup Capital line, aimed at boosting the growth of emerging companies with high technological potential.

On the 2nd and 3rd of June, the European University Hospital Alliance (EUHA) celebrated its 5th anniversary with a symposium at University Hospitals Leuven.

This award is given to people and organisations in recognition of outstanding contributions to the development of science and technology in Catalonia.

The drug EB1 is able to block resistance pathways to standard cancer treatments and could increase the efficacy of chemotherapy or immunotherapy.

EJP RD announces the release of the Innovation Management Toolbox (IMT), a tool created to provide self-help resources specific to the needs of researchers in this type of pathologies.